Edward Andrle

SR VP Strategy & Bus Dev, LivaNova PLC.

Companies

NEUROONE MEDICAL TECHNOLOGIES CorpBoard member Feb 21, 2020 to now¹
LivaNova PLCSR VP Strategy & Bus Dev Oct 22, 2015 to Jan 7, 2020²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

NEUROONE MEDICAL TECHNOLOGIES Corp NMTC133,932 shares³$139.3K at $1.04Apr 3, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Apr 3, 2026Granted 41,929 shares of NEUROONE MEDICAL TECHNOLOGIES Corp³
Feb 14, 2025Granted 27,778 shares of NEUROONE MEDICAL TECHNOLOGIES Corp⁴
Mar 16, 2023Granted 20,576 shares of NEUROONE MEDICAL TECHNOLOGIES Corp⁵
May 31, 2022Granted 29,240 shares of NEUROONE MEDICAL TECHNOLOGIES Corp⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARNEUROONE MEDICAL TECHNOLOGIES Corp, Board member
2
SEC EDGARLivaNova PLC, SR VP Strategy & Bus Dev
3
SEC EDGARNEUROONE MEDICAL TECHNOLOGIES Corp shares after the filing of Apr 3, 2026
4
SEC EDGARForm 4 filed Feb 19, 2025
5
SEC EDGARForm 4 filed Mar 20, 2023
6
SEC EDGARForm 4 filed Jun 2, 2022